What is cefoperazone-sulbactam injection used for?
Pharmaceutical Product Monograph: Cefoperazone & Sulbactam Sodium Injection
In the pharmaceutical industry, the combination of Cefoperazone and Sulbactam is a potent, synergistic Beta-lactam/Beta-lactamase Inhibitor (BLI). As a pharmacist and manufacturer at your WHO-GMP facility in Mumbai, I view this formulation as a “Resistant-Strain Specialist”—it is technically designed to combat serious infections where bacteria produce enzymes that would otherwise destroy standard cephalosporins.
This combination is a cornerstone of ICU and Critical Care medicine, particularly in the Asia-Pacific and African markets, due to its superior activity against Acinetobacter baumannii and Pseudomonas aeruginosa.
Therapeutic Profile: Primary Indications
Cefoperazone-Sulbactam is indicated for the treatment of severe, complicated infections caused by susceptible organisms, often where multi-drug resistance (MDR) is suspected.
| Indication | Clinical Context | Technical Rationale |
| Intra-abdominal Infections | Peritonitis / Cholangitis | Drug of Choice. High biliary excretion makes it ideal for gallbladder and gut infections. |
| Respiratory Tract | VAP / Nosocomial Pneumonia | Targets “Hospital-Acquired” bacteria that are often resistant to 1st/2nd Gen antibiotics. |
| Urinary Tract (UTI) | Pyelonephritis / Urosepsis | Effective against ESBL-producing E. coli and other complicated pathogens. |
| Septicemia | Bloodstream Infection | Used as an empirical heavy-duty intravenous treatment for systemic sepsis. |
| Gynecological | PID / Endometritis | Provides broad coverage for mixed aerobic and anaerobic pelvic infections. |
Mechanism: The “Synergistic Blockade”
This combination works through a dual-action biochemical strategy to bypass bacterial resistance:
Cefoperazone (The Executioner): A 3rd-generation cephalosporin that binds to Penicillin-Binding Proteins (PBPs). It inhibits bacterial cell wall synthesis, leading to osmotic lysis and cell death.
Sulbactam (The Bodyguard): A $\beta$-lactamase inhibitor. Many resistant bacteria produce enzymes (beta-lactamases) that “snip” the cephalosporin ring. Sulbactam binds irreversibly to these enzymes, “neutralizing” them so that Cefoperazone can do its job.
The Pharmacist’s “Technical Warning”
The “Disulfiram” Reaction: As a pharmacist, I must emphasize: Alcohol must be avoided during and for 3 days after treatment. Cefoperazone can interfere with alcohol metabolism, causing severe nausea, racing heart, and vomiting.
Coagulation Monitoring: The N-methylthiotetrazole side chain in Cefoperazone can interfere with Vitamin K metabolism. Patients on long-term therapy or anticoagulants (Warfarin) should have their Prothrombin Time (PT/INR) monitored.
The “Acinetobacter” Advantage: Technically, Sulbactam has its own intrinsic activity against Acinetobacter species, making this combination more effective against this specific “superbug” than Ceftriaxone or Ceftazidime.
Renal/Hepatic Balance: Because Cefoperazone is primarily excreted in the bile, it is generally safer for patients with kidney failure, though dose adjustments may be needed if both liver and kidney functions are impaired.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Fixed-Dose Ratio” USP: We manufacture this in 1:1 and 2:1 ratios (e.g., 1g:1g or 1g:0.5g). On your digital marketplace, highlight the 2:1 ratio (1.5g total) as the most common international standard for surgical prophylaxis and critical care.
Aseptic Powder Filling: Both ingredients are highly sensitive to moisture. Your WHO-GMP moisture-controlled “Dry Powder” suite ensures the stability of the $\beta$-lactam ring, providing a 24-month shelf life.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Cefoperazone-Sulbactam (1.5g and 3g) to support your registration in international B2B hospital supply contracts.